DIPPER Study: RCT Evaluating a Novel Force-Activated Separation
[Sponsored] While over 90% of inpatient admits in the US have a peripheral intravenous catheter (PIV) inserted, the rate of failure has been reported between 36% and 63%1, which can lead to significant delays in therapy and more importantly, costly IV restarts. These PIV failures are largely the result of mechanical complications. This randomized controlled trial evaluates a novel Force-Activated Separation Device (FASD) to determine its impact on PIV complication rates and delays in infusion therapy.
Download white paper to learn more
Sponsored By
ÍÃ×ÓÏÈÉúdoes not support or endorse connections products or services.
Fill out my .
Related Resources
Sponsored White Papers
This white paper explores four strategic ways in which research databases empower clinical educators and nursing leaders to accelerate a healthcare…
Sponsored White Papers
Nurse scheduling is no longer just an operational task, it's a strategic lever for improving staff satisfaction, reducing burnout, and building a…
Other Resources
AACN has partnered with the American Organization for Nursing Leadership (AONL) to announce the release of a new playbook to guide academic and…
Sponsored White Papers
While 74% of hospital leaders believe virtual care will play an important role in care delivery, most hospitals remain in the early stages of…
Other Resources
h2{
margin-top: 0px;
}
p.center_Intro {
color: #002855;
line-height: 1.2em;
font-size: 30px;
margin: 10px
Other Resources
The American Organization for Nursing Leadership (AONL) and its Workforce Committee are leading a national effort to unde stand and address nurse…